These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Renal Association Clinical Practice Guideline on cardiovascular disease in CKD. Holt S; Goldsmith D Nephron Clin Pract; 2011; 118 Suppl 1():c125-44. PubMed ID: 21555891 [No Abstract] [Full Text] [Related]
9. Assessing cardiovascular disease in the dialysis patient. Baig SZ; Coats WC; Aggarwal KB; Alpert MA Adv Perit Dial; 2009; 25():147-54. PubMed ID: 19886337 [TBL] [Abstract][Full Text] [Related]
10. The kidney in the pathophysiology and treatment of cardiovascular disease. Frishman WH Heart Dis; 2001; 3(3):139. PubMed ID: 11975782 [No Abstract] [Full Text] [Related]
11. [Cardiovascular diseases and modern prospects for preventing stroke]. Eliseev OM; Oshchepkova EV Ter Arkh; 2002; 74(9):73-8. PubMed ID: 12418127 [No Abstract] [Full Text] [Related]
12. Protein intake and chronic kidney disease: literature review, 2003 to 2008. Aparicio M J Ren Nutr; 2009 Sep; 19(5 Suppl):S5-8. PubMed ID: 19712877 [No Abstract] [Full Text] [Related]
13. [Cardiorenal anemic syndrome: clinical significance and therapeutic principles]. Kozlovskaia LV; Milovanov IuS; Fomin VV; Milovanova LIu Ter Arkh; 2005; 77(6):82-7. PubMed ID: 16078609 [No Abstract] [Full Text] [Related]
14. Plasma level of soluble Fas is an independent marker of cardiovascular disease in ESRD patients. Meier P; Blanc E Kidney Int; 2003 Oct; 64(4):1532-3. PubMed ID: 12969179 [No Abstract] [Full Text] [Related]
15. Chronic kidney disease: a new opportunity for better cardiovascular risk stratification. Hallan SI J Intern Med; 2009 Oct; 266(4):414-7. PubMed ID: 19765183 [No Abstract] [Full Text] [Related]
16. [Cancer of hormone-dependent tissues and problems of comorbidity (cardiovascular diseases, stroke, osteoporosis)]. Bershteĭn LM Vopr Onkol; 2010; 56(4):384-92. PubMed ID: 20968013 [No Abstract] [Full Text] [Related]
17. Improving a nation's cardiac health. Interview by Judy Ozkan, BA. Burns H Circulation; 2006 Apr; 113(13):f50-1. PubMed ID: 16596719 [No Abstract] [Full Text] [Related]
19. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection. Onuigbo MA Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease? Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]